
Carlsmed Inc (CARL) Stock Forecast & Price Target
Carlsmed Inc (CARL) Analyst Ratings
Bulls say
Carlsmed is expected to continue its upward trajectory as it leverages its AI-enabled technology and expands its customer base, while also managing potential challenges with strong clinical data and a focused approach to operational efficiency. With a potentially high ROI and look towards potential strategic partnerships or acquisitions, CARL could bring significant value to investors.
Bears say
Carlsmed is a commercial-stage medical technology company that operates in a highly competitive market with a negative demand outlook. Despite a favorable reimbursement structure and favorable clinical data showing a relative reduction in revision rates, the company's stock trades at a significant discount to its peers and has a high valuation multiple, which may result in pricing pressure and potential deleveraging in the future. Additionally, the company's expansion into the degenerative market may not be enough to offset any potential risks, such as slower adoption by surgeons or lower overall market growth rates.
This aggregate rating is based on analysts' research of Carlsmed Inc and is not a guaranteed prediction by Public.com or investment advice.
Carlsmed Inc (CARL) Analyst Forecast & Price Prediction
Start investing in Carlsmed Inc (CARL)
Order type
Buy in
Order amount
Est. shares
0 shares